These results also, in part, explain the effects achieved by OPN-neutralizing antibodies only in liver fibrosis and not in naïve mice, indicating its impact on promoting NKT cell activity and ameliorating liver fibrosis. This evidence concerns the gene SPP1 and Hepatic fibrosis.